Hertab 250 mg is a prescription anti-cancer medication containing Lapatinib, used to treat HER-2 positive advanced or metastatic breast cancer by blocking cancer cell growth. Manufactured by Hetero healthcare LTD. ,it is taken empty-stomach to inhibit cancer cell multiplication . it is often combined with other therapies.
Hormone therapy is a crucial cancer treatment that slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce these hormones or interfering with their receptor binding. It is used to shrink tumors before surgery , reduce recurrence risk after primary treatment and manage advanced or metastatic disease to improve survival rates.
WHAT IS HERTAB 250 MG?
Hertab 250 mg is classified as a targeted anti-cancer medication containing lapatinib. It belongs to the pharmacological class of tyrosine kinase inhibitors , specifically acting as a dual inhibitor of HER2 and EGFR receptors to treat HER2-positive breast cancer.
Key classification :
- · Active ingredient : lapatinib ditosylate (250 mg)
- · Therapeutic class: Antineoplastic Agent (Anti-cancer)
- Pharmacological class: tyrosine kinase inhibitor
- Mechanism of Action: inhibits HER2 and EGFr tyrosine kinase.
WHAT ARE THE MEDICAL USES OF HERTAB 250 MG TABLETS?
Medical uses of hertab 250 mg tablets are:
1. Treatment of prostrate prostrateprostrate cancer
Hertab 250 mg tablets (containing active ingredient Lapatinib ) are specifically used in the treatment of advanced or metastatic HER-2 positive breast cancer, not prostrate. It is a targated therapy ,specifically a tyrosine kinase inhibitor, which works by blocking HER2 and EGFR receptors responsible for breast cancer cell proliferation.
2. Metastatic castration-resistance prostrate cancer (Mcrpc)
Hertab 250 mg tablets contain Lapatinb , a tyrosine kinase inhibitor specifically approved for HER2 –positive advanced or metastatic breast cancer (mCRPC). It works by targeting ErbB1 (EGFR) and HER2 receptors. It is used for HER_2 positive breast cancer in combination with capecitabine or letrozol . for metastatic castration –resistance prostrate cancer (mCRPC) , standard therapies often include agents like arbiraterone acetate or enzalutamide.
3. Used in combination with corticosteroids
Hertab 250 mg tablets, which contains the active ingredient lapatinib ,are primarily used in combination with other anti-cancer drugs, most commonly capecitabine oe letrozole, for treating HER-2 positive advanced or metastatic breast cancer. While Hertab is often paired with chemotherapy or endocrine therapy , its use with corticosteroids is specialized and should only occur under the strict guidance of an oncologist.
WHAT ARE THE BENEFITS OF HERTAB 250 MG TABLETS?
Benefits of hertab 250 mg tablets are:
1. Slows progression of prostrate cancer
hertab 250 mg act as a kinase inhibitor that blocks HER2-POSITIVE and EGFR pathways to stop or slow the growth of cancer cells. The research results do not list Hertab as a standard treatment for prostrate cancer . research indicates that while some tyosinae kinase inhibitors may have potential ,one study specifically found that lapatinb did not suppress the progression in castration –resistance prostrate cancer models.
2. Reduces androgen levels efficacy
Hertab 250 mg is a targeted cancer therapy that works by blocking HER2 and EGFR proteins to stop cancer cell growth. It does not directly reduce androgen efficacy levels. Instead, it is often used in combination with hormonal therapy , such as letrozole, for treating hormone receptor –positive ,HER2- positive breast cancer .
3. Improves survival outcomes
Hertab 250 mg tablets, containing the active ingredient Lapatinib , are used to treat HER2 –positive advanced or metastatic breast cancer and have been shown to improve survival outcomes ,particularly when used in combination with other treatments. It is a targated therapy that blocks the HER2 and EGFR pathways, which are responsible for cell growth . studies have shown a disease control rate of around 61.7% in pateints with advanced HER2- overexpressing breast cancer.
WHAT ARE THE POSSIBLE SIDE EFFECTS OF HERTAB 250 MG?
Some of the side effects of Hertab 250 mg Tablets are:
1. Fatigue
Fatigue is a very common side effect of Hertab 250 mg tablets , which are used to treat certain types of HER2 –positive breast cancer. The medication can cause anemia leading to feelings of tiredness or weakness. It is advised to rest, relax and ensure one get adequate sleep . light physical activity, such as short walk, may help but, one should not overexert yourself.
2. Low potassium levels
Hertab 250 mg can lead to low potassium levels as a side effect, primarily because it causes severe diarrehea and vomiting ,which leads to fluid and electrolyte loss. The medication often causes severe diarrhea, a common side effect in up to 65% of pateints. This loss of bodily fluids results in an electrolyte imbalance , including low potassium. The doctor will likely monitor the electrolyte levels ,including potassium ,regularly during treatment.
3. Fluid retention
Hertab 250 mg tablet is a targated therapy ,and while its primary side effects focus on digestive issues and skin reactions. It can cause weight gain, and is often used alongside medications that cause fluid retention. Although rarer, severe fluid retention Can indicate serious complications ,such as cardiac problems , or pulmonary edema ,which can cause shortness of breath or sudden swelling in lungs/ arms.
4. Liver function changes
A significant risk associated with his medication is hepatotoxicity (liver damage), which can be severe or fatal . Hertab can cause changes in liver enzymes and bilirubin levels, sometimes leading to severe hepatoxicity . liver damage can occur within days or several months after starting treatment. The doctor will check one (LFT ) before starting ,during and after treatment to monitor for damage.
CONCLUSION
Hertab 250 mg is an effective targated therapy for HER-2 positive breast cancer ,often used after other treatments failed. It works by blocking cancer cell growth , usually in combination with other medicines. It is a potent treatment requiring close medical supervision, as it can have serious side effects like hepatotoxicity and diarrhea.
FREQUENTLY ASKED QUESTIONS (FAQs):
QUESTION: HOW LONG SHOULD HERTAB BE TAKEN?
Hertab 250 mg tablets are generally taken daily on an empty stomach for as long as the oncologist deems it effective in treating HER2-positive breast cancer . treatment is continued –often for several months –untill disease progression or unacceptable toxicity occurs.
QUESTION: CAN IT BE TAKEN WITH FOOD?
Hertab is typically recommended to be taken on an empty stomach to manage absorption . consuming this medication with food can increase the amount of drug absorbed by the body, which may affect its safety profile. It is generally recommended to take this medication at least one hour before or two hours after a meal.
QUESTION: IS IT USED ALONE OR WITH OTHER MEDICINES?
Hertab 250 mg tablet can be used either alone or in combination with other medications to treat HER_2 positive advanced or metastatic breast cancer . it is often prescribed in combination with other anti-cancer drugs, such as capecitabine or letrozole, depending on the specific treatment plan advised by an oncologist .
REFRENCES:
1)https://www.apothecare.in/products/hertab-250mg-tablet
2)https://drugcarts.com/product/hertab-tablet?srsltid=AfmBOoqS6gYFFtDbpLrJ_0pe1-vAqwru0fKLaL1zdzofe-xYBaCnrU3f
